BioHarvest Sciences ( (TSE:BHSC) ) has provided an update.
BioHarvest Sciences announced its participation in the WeBull Consumer Stocks Webinar on February 18, 2025, where CEO Ilan Sobel will present the company’s innovative approach to developing plant-based compounds using their patented Botanical Synthesis technology. This presentation will focus on the company’s direct-to-consumer business growth, the expanding VINIA® product line, and new opportunities in the CDMO services business. BioHarvest aims to impact key industries such as Nutraceuticals, Pharmaceuticals, Cosmeceuticals, and Nutrition by delivering consistent and economically viable plant compounds.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology platform to grow active plant ingredients without cultivating the plant itself. The company operates primarily in two business verticals: as a contract development and production organization (CDMO) for clients seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
YTD Price Performance: -3.41%
Average Trading Volume: 2,329
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$147.3M
For an in-depth examination of BHSC stock, go to TipRanks’ Stock Analysis page.